Life sciences environments do not need vague promises. They need discipline. In research, biopharma, quality-led production and controlled laboratory settings, standards around cleanliness, zoning, access, hygiene and routine execution all affect confidence, continuity and compliance. Buyers therefore need service partners that understand that even soft-services delivery has to be controlled, documented and easy to evidence.
TPMG is positioned to support life sciences sites with structured soft-services delivery across controlled estates and associated operational environments. Depending on the site and specification, that can include contract cleaning, deep and specialist cleaning, washroom and hygiene support, waste and recycling support, front of house support for campus and office environments, pest control, landscaping and mobilisation planning. Where a site operates under tighter cleanliness or contamination disciplines, the delivery model can be shaped around local procedures, access rules, zoning, supervision and documented service controls.
That structure matters because regulation is explicit. The revised EU GMP Annex 1 says contamination control strategy, design of premises, cleanroom classification, qualification, validation, monitoring and personnel gowning are core principles for sterile manufacturing environments, and the European Commission states the revised Annex 1 came into operation on 25 August 2023, with one later provision postponed to 25 August 2024. In parallel, the MHRA says organisations that may have to comply with GMP and GDP should prepare for inspection, and that it carries out inspections to check whether manufacturing and distribution sites comply.
That is why TPMG is positioned around mobilisation, routines, supervision, site audits, reporting and corrective-action follow-through. In life sciences, the estate should not feel loosely managed. It should feel stable, traceable and ready for scrutiny.